As opioid emergencies continue to be the leading cause of accidental death in the United States, Emergent BioSolutions (EBS) is teaming up with Voices for Awareness and Facing Fentanyl Now in honor of National Fentanyl Prevention and Awareness Day on August 21, 2025. As part of this year’s efforts, these leading advocacy organizations and its sponsors will bring their message to Times Square, NYC on the day with several high-visibility billboards that expose fentanyl risks and urge a nationwide call to action to reduce the stigma around opioid poisonings ensuring that more people can be prepared to save a life. Synthetic opioids, such as fentanyl, are a key driver of the opioid epidemic, contributing to nearly 70 percent of all overdose deaths.2 Its undetectable nature-lacking taste, smell, or visible characteristics-makes fentanyl particularly dangerous, and this partnership underscores a shared commitment to saving lives through increased public awareness.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EBS:
- Emergent BioSolutions’ AIGIV Study: A Potential Game-Changer in Anthrax Treatment
- Emergent BioSolutions’ AIGIV Study: A Key Development in Anthrax Treatment
- Emergent BioSolutions’ Earnings Call Highlights Strong Financial Performance
- Emergent Biosolutions: Strategic Advancements and Financial Performance Drive Buy Rating
- Emergent BioSolutions files $250M mixed securities shelf